Xcout Intel
CuraSen Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to CuraSen Therapeutics, Inc. among biotechnology companies — ranked by similarity to what CuraSen Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see CuraSen Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
CuraSen Therapeutics, Inc. at a glance
CuraSen Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $5.8M in August 2024. Xcout tracks 16 named people at CuraSen Therapeutics, Inc., including Anthony P Ford (President and Chief Executive Officer).
CuraSen Therapeutics, Inc. leadership
- Anthony P FordPresident and Chief Executive Officer
- Michael P. DillonChief Technical Officer
- Gabriel Vargas, MD, PhDChief Medical Officer
- Kathleen Sereda GlaubChief Executive Officer
- Anthony Ford, PhDPresident & Chief Scientific Officer
- Peter ButeraSenior Vice President, Operations
10 more named people on record for CuraSen Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
CuraSen Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5.8M | — | |
| Venture Round | $5.8M | 1 named | |
| SEC Form D filing | $17.6M | — | |
| SEC Form D filing | $18M | — | |
| SEC Form D filing | $27.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 CuraSen Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to CuraSen Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Neurawell Therapeutics is a clinical-stage research and development company that develops central nervous system (CNS) treatments. It focuses on addressing unmet medical needs for patients suffering from conditions such as depression, major depressive disorder, treatment-resistant depression, anxiety, and neurological disorders like Parkinson's disease.
Biotech
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Similar biotechnology company
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Similar biotechnology company
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 with headquarters in Copenhagen, Denmark, and operations in Leuven. The company discovers and develops novel therapies aimed at slowing or stopping devastating neurodegenerative diseases like Alzheimer's and Parkinson's.
Similar biotechnology company
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
Similar biotechnology company
FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.
Similar biotechnology company
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Biotech
Synendos Therapeutics is a clinical-stage biopharmaceutical and neuroscience company focused on developing a novel class of small molecules to treat psychiatric and neurological disorders.
Similar biotechnology company
Endurance Biotech, Inc. is a biopharmaceutical company that develops first-in-class oral small molecules designed to restore mitochondrial and lysosomal function for the treatment of neurodegenerative, metabolic, and age-related diseases. Its lead clinical program, T-168, targets Parkinson's disease by addressing interconnected cellular systems, reducing neuroinflammation, and enhancing autophagy.
Similar biotechnology company
FIVE DISCOVERY Corp is a biotechnology company that develops non-hallucinogenic neuroplastogen therapeutics designed to repair and stabilize dysfunctional neural circuits. The company serves patients suffering from neurodegenerative conditions and brain injuries, including Alzheimer's disease, Parkinson's disease, and traumatic brain injury.
Similar biotechnology company
Arkuda Therapeutics is a biotechnology company developing small-molecule treatments for neurodegenerative diseases, with a focus on restoring lysosomal function and addressing progranulin-related disease biology. Its programs are aimed particularly at patients with frontotemporal dementia and other disorders involving lysosomal dysfunction.
Similar biotechnology company
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CuraSen Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CuraSen Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →